Grace A Lin

Dr. Grace A. Lin is a Professor in the Department of Medicine at the University of California, San Francisco (UCSF) School of Medicine. She is a specialist in internal medicine and provides primary care, with a strong research focus on the appropriateness of medical care, shared decision-making, and the quality of clinical decisions. Her academic training includes an M.D. from the University of Michigan and an M.A.S. in Clinical Research from UCSF.

Her research centers on improving patient-centered care, reducing overuse of medical services, and evaluating health policy impacts—particularly in cardiology and chronic disease management. She has led NIH-funded research on decision quality in coronary artery disease and has published extensively on topics such as stress testing prior to percutaneous coronary intervention, patient decision aids, and cost-sharing in Medicare Part D. Her recent work explores Alzheimer’s disease biomarkers, multi-cancer early detection tests, and equity in access to specialty drugs.

Dr. Lin’s publication record from 2006 to 2025 shows a consistent focus on health services research, medical overuse, and policy evaluation. Her articles frequently appear in top journals like JAMA, Circulation, and JAMA Internal Medicine, and often involve collaboration with policy organizations such as the Institute for Clinical and Economic Review (ICER). The research spans cardiovascular care, geriatrics, oncology, neurology, and health economics, reflecting a broad interdisciplinary impact.

She is actively engaged in national health policy discussions, particularly around insurance coverage for high-cost drugs and diagnostic tests. Her work has influenced conversations on cost-effectiveness, value-based pricing, and equitable access to emerging therapies.

Dr. Lin has collaborated with prominent researchers such as Dr. Rita Redberg and Dr. Naomi Bardach at UCSF, and her research has been supported by the National Institutes of Health. She contributes to improving clinical practice through evidence-based policy analysis and patient-centered interventions.

She is affiliated with UCSF’s clinical and research infrastructure and maintains an active presence in academic medicine, with no indication of retirement or former status. Her work continues to shape discourse on healthcare quality, decision-making, and policy.